Assessment of Dopamine Release by in Vivo Microdialysis in the Nucleus Accumbens of Rats following Acute and Chronic Administration of Desipramine

Annals of the New York Academy of Sciences

Volumn 654, Issue 1, 1992, Pages 522-524

  SEE, RONALD E ^a   ADAMS‐CURTIS, LEAH ^a   ANN CHAPMAN, MARY ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESIPRAMINE; DOPAMINE;

ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DOPAMINE RELEASE; DRUG EFFECT; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMAL; DESIPRAMINE; DIALYSIS; DOPAMINE; HOMOVANILLIC ACID; HYDROXYINDOLEACETIC ACID; MALE; NUCLEUS ACCUMBENS; RATS; SUBSTANCE-RELATED DISORDERS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0026641441     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1992.tb26019.x     Document Type: Article

References (6)

1. Desipramine facilitation of initial cocaine abstinence.
2. Uptake inhibition of biogenic amines by newer anti‐depressant drugs: Relevance to the dopamine hypothesis of depression
3. Increased intracranial self‐administration in rats after long‐term administration of desipramine.
4. Behavioral evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine.
5. Chronic desipramine enhances amphetamine‐induced increases in interstitial concentrations of dopamine in the nucleus accumbens.
6. Clinical pharmacokinetics of imipramine and desipramine.